These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticoagulant therapy in pregnant women with mechanical heart valves. Leyh RT; Fischer S; Ruhparwar A; Haverich A Arch Gynecol Obstet; 2003 Apr; 268(1):1-4. PubMed ID: 12673466 [TBL] [Abstract][Full Text] [Related]
5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
6. [Anticoagulation in mechanical valve prostheses. A difficult situation]. Roudaut R; Roudaut MF; Labèque JN; Perron JM; Lafitte S; Jaïs C; Zabsonré P; Coste P Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1285-90. PubMed ID: 11794971 [TBL] [Abstract][Full Text] [Related]
7. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. James AH; Brancazio LR; Ortel TL Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990 [TBL] [Abstract][Full Text] [Related]
8. The use of low-molecular-weight heparins in pregnancy--how safe are they? Deruelle P; Coulon C Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136 [TBL] [Abstract][Full Text] [Related]
9. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism]. Gohlke-Bärwolf C Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944 [TBL] [Abstract][Full Text] [Related]
10. Prevention and management of venous thromboembolism in pregnancy. James AH Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457 [TBL] [Abstract][Full Text] [Related]
11. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573 [TBL] [Abstract][Full Text] [Related]
12. Minimising the risk of heparin-induced osteoporosis during pregnancy. Hawkins D; Evans J Expert Opin Drug Saf; 2005 May; 4(3):583-90. PubMed ID: 15934862 [TBL] [Abstract][Full Text] [Related]
13. Management of thromboembolism in pregnancy. Marks PW Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678 [TBL] [Abstract][Full Text] [Related]
14. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Kher A; Bauersachs R; Nielsen JD Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives]. Prandoni P; Simioni P; Pagnan A Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718 [TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation of pregnant women with mechanical heart valve prostheses]. Lindhoff-Last E; Schinzel H; Erbe M; Schächinger V; Bauersachs R Z Kardiol; 2001; 90 Suppl 6():125-30. PubMed ID: 11826815 [TBL] [Abstract][Full Text] [Related]
17. The safety of antithrombotic therapy during pregnancy. Ageno W; Crotti S; Turpie AG Expert Opin Drug Saf; 2004 Mar; 3(2):113-8. PubMed ID: 15006717 [TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. James AH; Brancazio LR; Gehrig TR; Wang A; Ortel TL J Matern Fetal Neonatal Med; 2006 Sep; 19(9):543-9. PubMed ID: 16966122 [TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]